![]() Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | ![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | ||
Founding Date | Founding Date 2012 | Founding Date 2013 | Founding Date 2013 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Berkeley, US HQ | Locations Cambridge, GB HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US |
Employees | Employees 1477% decrease | Employees 1192% decrease | Employees 20816% increase |
Valuation ($) | Valuation ($) 174.4 m | Valuation ($) N/A | Valuation ($) 256.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) $11.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2025) |
Net income | Net income ($148.1m) (FY, 2025) | Net income N/A | Net income ($160.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 159.5m | Total funding raised $ 11.3m | Total funding raised $ 210m |
Nuclera is a company that specializes in DNA synthesis.
View company
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View company